Opportunity Information: Apply for PA 13 216
Apply for PA 13 216
- The National Institutes of Health in the environment health income security and social services sector is offering a public funding opportunity titled "Research on Autism Spectrum Disorders (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113 Environmental Health 93.173 Research Related to Deafness and Communication Disorders 93.242 Mental Health Research Grants 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on May 1, 2013 and posted on May 1, 2013.
- Applicants must submit their applications by May 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments For profit organizations other than small businesses Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) County governments State governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Research on Autism Spectrum Disorders (R01) opportunity (Funding Opportunity Number PA-13-216) was a National Institutes of Health (NIH) discretionary grant program designed to support broad, investigator-initiated research on autism spectrum disorders (ASD). Using the NIH R01 mechanism, the announcement invited applications proposing basic, clinical, and applied studies that could improve understanding of ASD and strengthen real-world approaches to care. The central purpose was to encourage research that clarifies how ASD develops, how it can be identified and characterized, how it can be treated, and how services can be delivered more effectively across settings and populations.
In terms of scientific scope, the FOA emphasized multiple major research areas tied to ASD. It sought projects that illuminate etiology (the underlying causes and contributing biological, genetic, environmental, and developmental factors), epidemiology (patterns, prevalence, risk factors, and population-level trends), diagnosis (methods, tools, and criteria that improve identification and differentiation of ASD and related conditions), treatment (behavioral, educational, pharmacologic, and other interventions, including studies of efficacy, effectiveness, and outcomes), and service delivery (how to organize, implement, and optimize systems of supports and services so individuals with ASD and their families can access appropriate care across the lifespan). By explicitly welcoming basic, clinical, and applied research, the announcement supported everything from foundational laboratory or mechanistic work through translational and practice-oriented studies that aim to improve interventions and service systems.
Administratively, this was a grant funding instrument under an FOA posted and created on May 1, 2013. The original and final closing date listed for the announcement was May 7, 2016, and the archive date was June 7, 2016, meaning the opportunity is no longer open for new applications under that specific announcement. The program did not require cost sharing or matching funds, which can make participation more feasible for a wide range of applicants and research settings.
Eligibility was intentionally broad. Eligible applicants included many types of U.S.-based organizations such as state, county, city or township governments; special district governments; independent school districts; and public housing authorities/Indian housing authorities. Higher education institutions were eligible, including private institutions of higher education and public/state-controlled institutions of higher education. The FOA also allowed nonprofit organizations both with and without 501(c)(3) status (as specified in the listing), as well as for-profit organizations (other than small businesses) and small businesses. In addition, it included a wide variety of mission- or population-focused eligible entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Faith-based and community-based organizations were also listed as eligible, along with eligible agencies of the federal government, U.S. territories or possessions, and regional organizations.
The announcement also permitted international participation in several forms. Non-domestic (non-U.S.) entities (both foreign organizations and foreign institutions) were eligible to apply. Non-domestic components of U.S. organizations could apply, and foreign components were allowed as defined under the NIH Grants Policy Statement. This structure opened the door for cross-national collaborations and studies that may require international cohorts, specialized expertise, or unique research infrastructures.
The FOA was associated with multiple CFDA program areas reflecting NIH institutes and missions that commonly intersect with ASD research. The CFDA numbers listed were 93.113 (Environmental Health), 93.173 (Research Related to Deafness and Communication Disorders), 93.242 (Mental Health Research Grants), 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders), and 93.865 (Child Health and Human Development Extramural Research). Together, these categories signal that ASD research supported under this announcement could span environmental influences, communication and language development, mental health and behavioral outcomes, neuroscience and neurological mechanisms, and child development and health services.
For applicants or readers seeking the original full text, the NIH provided an official announcement link at http://grants.nih.gov/grants/guide/pa-files/PA-13-216.html. For access or technical issues, the contact point in the listing was the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV, specifically for difficulty accessing the announcement or problems linking to it.
Frequently Asked Questions (FAQ)
What is the "Research on Autism Spectrum Disorders (R01)" funding opportunity?
It was a National Institutes of Health (NIH) discretionary grant program titled "Research on Autism Spectrum Disorders (R01)" under Funding Opportunity Number (FON) PA-13-216. It used the NIH R01 mechanism to support broad, investigator-initiated research on autism spectrum disorders (ASD).
What was the main purpose of PA-13-216?
The central purpose was to encourage research that clarifies how ASD develops, how it can be identified and characterized, how it can be treated, and how services can be delivered more effectively across settings and populations.
What types of research were invited under this R01 announcement?
The announcement invited basic, clinical, and applied studies. This included work ranging from foundational laboratory or mechanistic research through translational and practice-oriented studies intended to improve interventions and service systems.
What ASD topic areas were emphasized in the scientific scope?
The FOA emphasized multiple major areas tied to ASD, including:
- Etiology (underlying causes and contributing biological, genetic, environmental, and developmental factors)
- Epidemiology (patterns, prevalence, risk factors, and population-level trends)
- Diagnosis (methods, tools, and criteria to improve identification and differentiation of ASD and related conditions)
- Treatment (behavioral, educational, pharmacologic, and other interventions; including efficacy, effectiveness, and outcomes)
- Service delivery (organizing, implementing, and optimizing systems of supports/services across the lifespan so individuals and families can access appropriate care)
Was this opportunity focused only on clinical trials or only on basic science?
No. The FOA explicitly welcomed basic, clinical, and applied research, supporting a wide spectrum from mechanistic work through real-world, practice-oriented studies.
What grant mechanism was used for this opportunity?
The opportunity used the NIH R01 research project grant mechanism.
When was PA-13-216 posted?
The FOA was posted/created on May 1, 2013.
Is PA-13-216 still open for new applications?
No. The original and final closing date listed was May 7, 2016. The archive date was June 7, 2016, which indicates the opportunity is no longer open for new applications under that specific announcement.
Did this program require cost sharing or matching funds?
No. The program did not require cost sharing or matching funds.
Who was eligible to apply?
Eligibility was broad and included many U.S.-based organizations, such as:
- State, county, city, or township governments
- Special district governments
- Independent school districts
- Public housing authorities / Indian housing authorities
- Public/state-controlled institutions of higher education
- Private institutions of higher education
- Nonprofits with 501(c)(3) status (as specified in the listing)
- Nonprofits without 501(c)(3) status (as specified in the listing)
- For-profit organizations (other than small businesses)
- Small businesses
- Faith-based organizations
- Community-based organizations
- Eligible agencies of the federal government
- U.S. territories or possessions
- Regional organizations
Were minority-serving institutions included as eligible applicants?
Yes. The FOA listed multiple mission- or population-focused institutions as eligible, including:
- Historically Black Colleges and Universities (HBCUs)
- Hispanic-serving Institutions
- Tribally Controlled Colleges and Universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
Could international (non-U.S.) organizations apply?
Yes. Non-domestic (non-U.S.) entities (both foreign organizations and foreign institutions) were eligible to apply.
Could a U.S. organization include an international component in its application?
Yes. Non-domestic components of U.S. organizations could apply, and foreign components were allowed as defined under the NIH Grants Policy Statement.
What kinds of collaborations did the eligibility structure support?
Because foreign entities and foreign components were allowed, the structure could support cross-national collaborations and studies that require international cohorts, specialized expertise, or unique research infrastructure.
Which CFDA numbers were associated with this FOA?
The FOA was associated with multiple CFDA program areas, specifically:
- 93.113 - Environmental Health
- 93.173 - Research Related to Deafness and Communication Disorders
- 93.242 - Mental Health Research Grants
- 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders
- 93.865 - Child Health and Human Development Extramural Research
What do the listed CFDA areas suggest about the kinds of ASD research that could fit?
Together, these CFDA categories indicate the supported ASD research could span environmental influences, communication and language development, mental health and behavioral outcomes, neuroscience and neurological mechanisms, and child development and health services.
Where can someone find the official NIH announcement text for PA-13-216?
The official NIH announcement link provided was: http://grants.nih.gov/grants/guide/pa-files/PA-13-216.html
Who should be contacted if there are technical issues accessing the announcement link?
For difficulty accessing the announcement or problems linking to it, the listing identified the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What does it mean that this was an NIH "discretionary" grant program?
Based on the listing, it was described as an NIH discretionary grant program supporting investigator-initiated ASD research using the R01 mechanism.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Environment Health Income Security and Social Services
Next opportunity: Research on Autism Spectrum Disorders (R21)
Previous opportunity: BLM NOC National Resources Inventory Project
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 216
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 216) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research on Autism Spectrum Disorders (R21) Apply for PA 13 217 Funding Number: PA 13 217 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
| Research on Autism Spectrum Disorders (R03) Apply for PA 13 218 Funding Number: PA 13 218 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $50,000 |
| Developmental Pharmacology and Toxicology Role of Ontogeny (R21) Apply for PAR 13 308 Funding Number: PAR 13 308 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
| Developmental Pharmacology and Toxicology Role of Ontogeny (R03) Apply for PAR 13 307 Funding Number: PAR 13 307 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $50,000 |
| Developmental Pharmacology and Toxicology Role of Ontogeny (R01) Apply for PAR 13 306 Funding Number: PAR 13 306 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Environmental Contributors to Autism Spectrum Disorders (R01) Apply for PAR 14 203 Funding Number: PAR 14 203 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $400,000 |
| Environmental Contributors to Autism Spectrum Disorders (R21) Apply for PAR 14 202 Funding Number: PAR 14 202 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
| Centers of Excellence on Environmental Health Disparities Research (P50) Apply for RFA ES 14 010 Funding Number: RFA ES 14 010 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $1,000,000 |
| Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54) Apply for PAR 15 146 Funding Number: PAR 15 146 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21) Apply for PAR 15 315 Funding Number: PAR 15 315 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Genetic Susceptibility and Variability of Human Structural Birth Defects (R01) Apply for PA 08 011 Funding Number: PA 08 011 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Pharmacology (R03) Apply for PAR 08 215 Funding Number: PAR 08 215 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Pharmacology (R21) Apply for PAR 08 216 Funding Number: PAR 08 216 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
| Genetic and Genomic Analysis of Xenopus (R01) Apply for PAR 09 240 Funding Number: PAR 09 240 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Genetic and Genomic Analysis of Xenopus (R21) Apply for PAR 09 241 Funding Number: PAR 09 241 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
| Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01) Apply for PAR 10 180 Funding Number: PAR 10 180 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54) Apply for PAR 10 181 Funding Number: PAR 10 181 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Pharmacology (R01) Apply for PAR 11 057 Funding Number: PAR 11 057 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $499,999 |
| Developmental Pharmacology (R03) Apply for PAR 11 058 Funding Number: PAR 11 058 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $50,000 |
| Developmental Pharmacology (R21) Apply for PAR 11 059 Funding Number: PAR 11 059 Agency: National Institutes of Health Category: Environment Health Income Security and Social Services Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 216", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.